[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4398 followers
Created: 2025-07-25 13:30:08 UTC

$KRYS New Product Launches:

On July 25, 2025, Krystal Biotech, Inc. announced that Japan's Ministry of Health approved its product VYJUVEK® for treating Dystrophic Epidermolysis Bullosa.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948737533153562947/c:line.svg)

**Related Topics**
[sec](/topic/sec)
[$krys](/topic/$krys)

[Post Link](https://x.com/USCorpFilings/status/1948737533153562947)